Based in Irvine, California, Biren Mehta is the Vice President, Venture Investments—MedTech, Johnson & Johnson, where he initiates and manages equity investments to drive business innovation and deliver new and sustainable business for the MedTech sector. He is responsible for existing and new MedTech investments on the West Coast, ensuring targeted strategic options are shaped for success. Biren plays a critical role in building and maintaining networks in the venture capital community, entrepreneurs, startups, incubators and accelerators and other venture organizations that fit the strategic interests of the MedTech sector, sourcing new opportunities for the sector and positioning JJDC as the partner of choice.

​

Most recently, Biren was Vice President of Business Development for the Cardiovascular & Specialty Solutions (CSS) Group and J&J Vision. This represents a portfolio of six diverse, high-growth businesses within MedTech.  In this role, he provided strategic leadership in executing acquisitions, investments, distribution transactions, and other collaborations to support the growth and innovation agenda of these businesses.

​

Prior to joining Johnson & Johnson, Biren was a medical device analyst at Roth Capital Partners. In that role, he wrote and published recommendations on publicly traded small and midcap medical device companies. Before joining the investment bank, he worked as a project manager and software engineer at Intralase Corporation, now owned by J&J Surgical Vision.

​

Biren completed his bachelor’s degree in Cybernetics at UCLA. He earned master’s degrees in Biomedical Engineering and Computer Science from the University of Southern California. He also earned his MBA from the UCLA Anderson School of Management.